ANTELLIQ
Acquired by
MERCK & CO.
ANTELLIQ acquired by MERCK & CO.
Target
ANTELLIQ
Acquirer
MERCK & CO.
Context
The global life sciences leader has finalized the acquisition of 100% of the share capital of the target from a prominent European private equity firm. This strategic transaction represents a definitive move to incorporate advanced digital capabilities into the group’s specialized animal health division, targeting the high-growth segment of animal intelligence and monitoring. The strategic rationale for the move centers on the acquirer's objective to provide integrated, data-driven health management solutions that complement its existing portfolio of vaccines and medicines. By incorporating this technical specialist, the organization reinforces its ability to offer comprehensive traceability and real-time health insights for livestock and companion animals. The partnership is designed to leverage the acquirer’s global reach and research infrastructure to accelerate the development of next-generation monitoring technologies. This integration facilitates the creation of a premier digital platform in the animal health market, providing the strategic depth required to address the rising demand for food security and enhanced pet longevity.
ANTELLIQ, which reported an EBITDA margin of LOGIN in 2018, is valued in this transaction at an EV/EBITDA multiple of LOGIN, a level around LOGIN higher than the 13.4x average currently observed in the Healthcare & Pharma sector.
Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.
-> Deep-dive in Healthcare & Pharma market trends
Target
Antelliq is a specialized technology organization dedicated to the development and deployment of digital identification, traceability, and monitoring solutions for animals. The entity’s business model focuses on providing high-precision hardware and data analytics to facilitate the management of livestock and companion animals. Its value proposition is anchored in enhancing animal welfare and productivity through real-time health and behavioral insights. Strategically, the firm operates at the intersection of veterinary science and digital reality, utilizing proprietary sensors and tracking software to provide actionable data for farmers and veterinarians. By maintaining a leadership position in the global animal intelligence market, the organization ensures a mission-critical role in the agricultural supply chain and pet care ecosystems. The entity emphasizes industrialized reliability to address the increasing demand for food safety and personalized animal care.
Ent. Value
LOGIN
Equity Value
LOGIN
Multiples Analysis
EV / Revenue
LOGIN
EV / EBITDA
LOGIN
EV / EBIT
LOGIN
Historical Financials (EUR)
Other operations with ANTELLIQ
| Date | Acquirer | Target | Country | Sector | Deal Context |
|---|---|---|---|---|---|
| 03/2016 | PSP INVESTMENTS | ANTELLIQ | FRANCE | Animal Health | The global life sciences leader has successfully finalized a definitive agreement to acquire the total share capital of the target from a consortium led by a prominent European private equity firm and a Canadian institutional investor. This strategic transaction represents a transformative integration for the group’s specialized animal health division, marking a definitive shift toward a data-driven service model. The strategic rationale for the move centers on the convergence of the animal intelligence and animal health industries, where the target’s digitally connected identification and monitoring products provide a significant competitive advantage. |
| 06/2013 | BC PARTNERS | ANTELLIQ | FRANCE | Animal Health | BC Partners has successfully finalized the acquisition of a majority stake in the share capital of the target from a UK-based investment trust. This strategic transaction represents a secondary leveraged buyout designed to accelerate the organization’s shift toward electronic identification and digital monitoring technologies. The strategic rationale for the move centers on the acquirer's objective to capitalize on the increasing global adoption of mandatory livestock traceability and the rising demand for sophisticated animal intelligence solutions. |
mynth data is contributed by M&A / PE professionals and systematically cross-verified against private deal documents and official releases. All source materials are destroyed post-validation to guarantee data anonymity and compliance.